Does VEDOLIZUMAB Cause Vitreous floaters? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Vitreous floaters have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.0% of all adverse event reports for VEDOLIZUMAB.
20
Reports of Vitreous floaters with VEDOLIZUMAB
0.0%
of all VEDOLIZUMAB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Vitreous floaters From VEDOLIZUMAB?
Of the 20 reports, 1 (5.0%) resulted in death, 3 (15.0%) required hospitalization.
Is Vitreous floaters Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Vitreous floaters?
AFLIBERCEPT (690)
BROLUCIZUMAB-DBLL (479)
RANIBIZUMAB (458)
BEVACIZUMAB (323)
ADALIMUMAB (300)
DUPILUMAB (300)
CIPROFLOXACIN (189)
FINGOLIMOD (129)
FARICIMAB\FARICIMAB-SVOA (123)
UPADACITINIB (112)
Which VEDOLIZUMAB Alternatives Have Lower Vitreous floaters Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB